Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02222259 |
Date of registration:
|
18/08/2014 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients
|
Scientific title:
|
A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients (A GEM Study for Older Cancer Patients) |
Date of first enrolment:
|
September 2014 |
Target sample size:
|
60 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02222259 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Outcomes Assessor).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Canada
| | | | | | | |
Contacts
|
Name:
|
Martine Puts, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of Toronto |
|
Name:
|
Shabbir Alibhai, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University Health Network, Toronto |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Clinical diagnosis of advanced (stage 2, 3 or 4) Gastrointestinal, Genitourinary, or
breast cancer
- Referred for first-line chemotherapy
- Ability to speak English
- Physician estimated life expectancy >6 months
- An Eastern Oncology Group Collaborative (ECOG) Performance Score of 0-2
- Ability to provide informed consent
Exclusion Criteria:
- Previous chemotherapy for current stage of disease
Age minimum:
70 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Gastrointestinal Cancer
|
Breast Cancer
|
Genitourinary Cancer
|
Intervention(s)
|
Procedure: GA and Integrated Care Plan
|
Primary Outcome(s)
|
Quality of life
[Time Frame: 6 months]
|
Secondary Outcome(s)
|
Impact of the Geriatric Assessment (GA) on the cancer treatment decision questionnaire
[Time Frame: 6 months]
|
Functional status
[Time Frame: 6 months]
|
Secondary ID(s)
|
14-7879-CE
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|